Chemoinformaics analysis of 2-OXAZOLIDINETHIONE, 5-ETHYL-5-METHYL-, (S)-
| Molecular Weight | 145.227 | nRot | 1 |
| Heavy Atom Molecular Weight | 134.139 | nRig | 6 |
| Exact Molecular Weight | 145.056 | nRing | 1 |
| Solubility: LogS | -1.453 | nHRing | 1 |
| Solubility: LogP | 1.865 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.1567 |
| nHD | 1 | BPOL | 14.5713 |
| QED | 0.557 |
| Synth | 4.325 |
| Natural Product Likeliness | 1.535 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.018 |
| CACO-2 | -4.357 |
| MDCK | 0.0000468 |
| BBB | 0.972 |
| PPB | 0.477208 |
| VDSS | 1.228 |
| FU | 0.621134 |
| CYP1A2-inh | 0.394 |
| CYP1A2-sub | 0.762 |
| CYP2c19-inh | 0.562 |
| CYP2c19-sub | 0.862 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.212 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.295 |
| CYP3a4-inh | 0.391 |
| CYP3a4-sub | 0.255 |
| CL | 8.21 |
| T12 | 0.699 |
| hERG | 0.016 |
| Ames | 0.041 |
| ROA | 0.878 |
| SkinSen | 0.404 |
| Carcinogencity | 0.903 |
| EI | 0.317 |
| Respiratory | 0.674 |
| NR-Aromatase | 0.062 |
| Antiviral | No |
| Prediction | 0.937458 |